Mycoplasma genitalium Throat Infections
Pharyngeal M. genitalium infection is exceedingly rare and does not require routine testing or treatment, as this organism rarely colonizes the throat and is not considered a clinically significant cause of pharyngitis 1.
Key Clinical Context
M. genitalium is primarily a urogenital pathogen that causes urethritis, cervicitis, and pelvic inflammatory disease. While the organism has been isolated from throat specimens in historical research 2, current evidence demonstrates that pharyngeal infection is extremely uncommon in clinical practice 1.
Why Throat Testing Is Not Recommended
M. genitalium rarely infects the pharynx - unlike N. gonorrhoeae and C. trachomatis, which commonly cause oropharyngeal infections in high-risk populations (particularly MSM), M. genitalium does not establish clinically relevant pharyngeal infections 1
The 1988 study that identified M. genitalium in throat specimens found it as mixed infections with M. pneumoniae, suggesting laboratory cross-contamination or transient colonization rather than true infection 2
Current guidelines from multiple sources (CDC, BASHH, IDSA) do not recommend pharyngeal testing for M. genitalium, even in high-risk populations where extragenital site testing is standard for gonorrhea and chlamydia 3, 1, 4
When M. genitalium Testing IS Indicated
Testing should be focused on urogenital sites in specific clinical scenarios 4:
- Persistent male urethritis (after treatment failure for gonorrhea/chlamydia)
- Cervicitis in women
- Proctitis (rectal infection does occur and may cause symptoms)
- Pelvic inflammatory disease (consider testing)
- Sexual contacts of confirmed M. genitalium cases
Diagnostic Approach
If pharyngeal symptoms are present, consider:
- Alternative diagnoses: Group A Streptococcus, viral pharyngitis, N. gonorrhoeae (in high-risk patients), or M. pneumoniae for respiratory symptoms
- Do not test throat specimens for M. genitalium - no FDA-approved tests are validated for pharyngeal specimens, and clinical significance is not established 4
Important Caveat
The historical isolation of M. genitalium from throat specimens 2 occurred in the context of M. pneumoniae vaccine trials and likely represents either:
- Laboratory identification challenges due to antigenic cross-reactivity between species
- Transient colonization without clinical disease
- Contamination from urogenital sources
Bottom Line
There is no role for diagnosing or treating M. genitalium throat infections in routine clinical practice. Focus testing on urogenital and rectal sites where the organism causes established disease with documented morbidity 1, 4. If a patient has confirmed urogenital M. genitalium infection, treat according to resistance-guided protocols (doxycycline followed by azithromycin or moxifloxacin), but do not extend testing or treatment to the pharynx 4.